Answers are grounded in this paper and cite their sources.
The chemically unrelated hypolipidemic drugs, tiadenol, niadenate, and clofibrate have been tested for carcinogenic and tumor-promoting potential in the C3H/10TI/2 C18 cell test system. None of these chemicals were carcinogenic, while both niadenate and clofibrate were active tumor promoters at micromolar concentrations. All 3 drugs induced the differentiation of C3H/10T1/2 C18 cells to adipocytes. This latter finding confirms previously observed effects of the tumor promoter TPA.
No takes yet. Share an insight, caveat, or question.
Lillehaug et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: